JD Health International Logs 94% Higher Attributable Profit for 2024

Published on 06/03/2025 at 21:41 - Modified on 06/03/2025 at 21:53

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about JD Health International Inc.

Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	11/06	MT
China, HK shares rise as banks and carmakers rally; trade talks eyed	03/06	RE
Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy	15/05	MT
JD Health International's Profit Jumps 4.6% in Q1	13/05	MT
JD Health International Posts Q1 Revenue Of RMB16.65 Billion	13/05	RE
Nomura Adjusts JD Health International's Price Target to HK$41.50 From HK$31, Keeps at Buy	10/03	MT
JD Health International Inc. Provides Revenue Guidance for the Year 2025	06/03	CI
JD Health International Inc., 2024 Earnings Call, Mar 06, 2025	06/03
JD Health International Logs 94% Higher Attributable Profit for 2024	06/03	MT
JD Health International Posts FY Revenue Of RMB 58,200 Million	06/03	RE
JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	06/03	CI
DeepSeek, Tariff Relief Drive Rally in Chinese Tech Stocks	14/02	DJ
Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	18/11	MT
JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	15/11	MT
JD Health International Grants Share Awards Under Post-IPO Award Scheme	02/10/24	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	19/08/24	MT
Hong Kong Stocks Extend Gains on US Rate Cut Hopes; Holly Futures Jumps 15%	19/08/24	MT
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/08/24	RE
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/08/24	RE
JD Health International Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	15/08/24	CI
JD Health's H1 Profit Surges to 2 Billion Yuan	15/08/24	MT
JD Health International Inc., H1 2024 Earnings Call, Aug 15, 2024	15/08/24
JD Health International Inc. Announces Appointment of Professor George Lau as Independent Non-Executive Director	15/08/24	CI
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	17/07/24	MT
JD.com's Healthcare Arm Shuttering Family Doctor Initiative	29/05/24	MT